Primary endpoint analysis of anti-PT antibody at Day 28 post-vaccination in the pooled population (pregnant women and non-pregnant women of childbearing age)
Adjusted GMC ratios of the anti-PT antibody of each group with the comparator, Tdap8Anti-PT IgG in the pooled population of pregnant women and women of childbearing age, and antibody concentration/titers (anti-PT IgG, anti-FHA IgG and PT neutralizing antibody) in pregnant women at 28 days after vaccination.